天然产物研究与开发 ›› 2026, Vol. 38 ›› Issue (8): 1706-1712.doi: 10.16333/j.1001-6880.2026.8.009 cstr: 32307.14.1001-6880.2026.8.009

• 研究简报 • 上一篇    下一篇

中华大蟾蜍卵中2个蟾毒内酯类新化合物及其抗乳腺癌活性研究

张鹏伟1,2*,吴  佳3,田海妍2,黄  露1,吕俊芳4   

  1. 1广州中医药大学第二附属医院,广州 510120;2暨南大学药学院,广州 510632;3广州中医药大学附属广东省中西医结合医院,佛山 528200;4香港中文大学中医药研究所,香港 999077
  • 出版日期:2026-08-27 发布日期:2026-08-26
  • 基金资助:
    广东省中医药局科研基金(20241122,20254048);广东省中医院-香港中文大学协同创新项目(YN2023QN14,YN2024HK14)

Two novel bufadienolides from the eggs of toad Bufo gargarizans and their anti-breast cancer activity

ZHANG Peng-wei1,2*,WU Jia3,TIAN Hai-yan2,HUANG Lu1,LYU Jun-fang4   

  1. 1The Second Affiliated Hospital of Guangzhou University of Chinese Medicine,Guangzhou 510120,China;2School of Pharmacy,Jinan University,Guangzhou 510632,China; 3Guangdong Provincial Hospital of Integrated Traditional Chinese and Western Medicine,Guangzhou University of Chinese Medicine,Foshan 528200,China,4Institute of Chinese Medicine,the Chinese University of Hong Kong,HongKong 999077,China
  • Online:2026-08-27 Published:2026-08-26

摘要:

为探究中华大蟾蜍卵中化学成分,通过多种柱色谱技术对其二氯甲烷萃取物进行分离纯化,综合运用NMR、MS、UV等手段鉴定化合物结构,并采用MTT法对这些化合物的抗人乳腺癌细胞系MCF-7和MDA-MB-231的体外增殖活性进行评价。总共分离得到5个化合物,分别为3-(14-hydroxy-7Z-tetradecenoyl)-hellebrigenol(1)、3-(16-hydroxy-9Z-hexadecanoyl)-hellebrigenol(2)、3-(14-hydroxy-7Z-tetradecenoyl)-1β-hydroxytelecinobufagin(3)、3-(14-hydroxy-tetradecanoyl)-hellebrigenol(4)、3-氧代沙蟾蜍精(5)。其中化合物1和2为新化合物,化合物5作为天然产物首次报道。活性测试结果显示,所有化合物均有较强的抗乳腺癌活性,新化合物1和2对三阴性乳腺癌细胞系MDA-MB-231的IC50分别为0.230 ± 0.028、0.215 ± 0.064 μmol/L。

关键词:

蟾蜍, 蟾毒内酯, 脂肪酸酯, 抗乳腺癌活性

Abstract:

To investigate the chemical constituents in eggs of Bufo gargarizans, the dichloromethane extract was subjected to isolation and purification using various chromatographic techniques. Compound structures were elucidated through comprehensive methods such as NMR, MS, and UV spectroscopy, with in vitro anti-breast cancer cell MCF-7and MDA-MB-231activity evaluated via the MTT assay. Five compounds were isolated and identified as 3-(14-hydroxy-7Z-tetradecenoyl)-hellebrigenol (1), 3-(16-hydroxy-9Z-hexadecanoyl)-hellebrigenol (2), 3-(14-hydroxy-7Z-tetradecenoyl)-1β-hydroxytelecinobufagin (3), 3-(14-hydroxy-tetradecanoyl)-hellebrigenol (4), and 3-oxo-arenobufagin (5). Compounds 1 and 2 are novel, while 5 is a newly reported natural product. The activity test results showed that all compounds exhibited significant anti-breast cancer activities. The IC50 values of compounds 1 and 2 against the triple-negative breast cancer cell line MDA-MB-231 were 0.230 ± 0.028 and 0.215 ± 0.064 μmol/L, respectively.

Key words:

 toad Bufo gargarizans, bufadienolides, fatty acid esters, anti-breast cancer activity

中图分类号:  R284','1');return false;" target="_blank"> R284 R915','1');return false;" target="_blank"> R915